US 11116823
Treatment of α-galactosidase a deficiency
granted A61KA61K38/00A61K38/47
Quick answer
US patent 11116823 (Treatment of α-galactosidase a deficiency) held by Takeda Pharmaceutical Company Limited expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K38/00, A61K38/47, A61P, A61P13/12